Intel now says it is selling $20 billion of stock
1 min read
The story
Intel said Tuesday that it is increasing the size of its offering of new shares by an additional $5 billion, taking the planned stock sale to $20 billion. The transaction is intended to raise capital through equity issuance, but the larger offering also means greater potential dilution for existing shareholders.
The financing lands against a mixed operating backdrop. Intel reported $52.9B of revenue for FY 2025, down -0.5% YoY, with a 34.8% gross margin, a -0.5% net margin, and dilutive EPS of $-0.06.
The second-order setup is a trade-off between balance-sheet funding and shareholder dilution. The capital could support Intel’s strategic plans, but the immediate financing signal is more punitive because the company is raising substantially more equity while profitability remains negative.
The key tension is execution: stronger operating performance could make the new capital more productive, while continued weak earnings would leave the enlarged share count as the clearest near-term overhang. The offering terms, final share count, use of proceeds, and subsequent margin trajectory are the next markers.
The case — both sides
The strongest bull case is that the $20 billion of new capital materially strengthens Intel’s strategic execution despite its current -0.5% net margin.
The bear case is better grounded near term: an additional $5 billion of issuance expands dilution while revenue is down -0.5% YoY and dilutive EPS is $-0.06; the opposing case has no disclosed operating improvement in the supplied data.
The house read
Leans bearThe enlarged $20 billion equity raise moves the immediate risk to the downside for INTC, with dilution landing alongside -0.5% net margins and $-0.06 dilutive EPS.
Wrong ifA sharply accretive use of proceeds, unexpectedly favorable offering terms, or a clear improvement in margins could reverse the dilution-led downside read.
Published read · research, not advice